Kades & Cheifetz »

Arbutus Biopharma shares owned by Kades & Cheifetz

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Kades & Cheifetz from 13F filings

Historical chart of Kades & Cheifetz investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Kades & Cheifetz consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Kades & Cheifetz

Quarter filed Position value Share count Share price at filing
2023-12-31 $50k 20k 2.50
2023-09-30 $41k 20k 2.03
2023-03-31 $61k 20k 3.03
2022-12-31 $47k 20k 2.33

More positions owned by Kades & Cheifetz

Schwab Strategic Tr Us Dividend Eq (SCHD)
Spdr Ser Tr S&P 600 SMCP GRW (SLYG)
Vanguard Specialized Funds Div App Etf (VIG)
Apple (AAPL)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Spdr Ser Tr Nuveen Blmbrg Sh (SHM)
Ishares Gold Tr Ishares New (IAU)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Ishares Tr Conv Bd Etf (ICVT)
Strategy Ns 7handl Idx (HNDL)
Ishares Tr Pfd And Incm Sec (PFF)
Wisdomtree Tr Us Smallcap Divd (DES)
Schwab Strategic Tr 1 5yr Corp Bd (SCHJ)
Invesco Exch Traded Fd Tr Ii Pfd Etf (PGX)
Ishares Tr National Mun Etf (MUB)

View all positions for Kades & Cheifetz

Top funds holding Arbutus Biopharma

Whitefort Capital Management
Vanguard Group
Hudson Bay Capital Management
ADAR1 Capital Management
Centiva Capital
Citadel Advisors
Millennium Management
Advisor Group Holdings
FourWorld Capital Management
Citigroup
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Barclays
Bank Of Montreal

View all funds holding Arbutus Biopharma